


文档简介
ProductDataSheetDHEACat.No.:HY-14650CASNo.:53-43-0分⼦式:C₁₉H₂₈O₂分⼦量:288.42作⽤靶点:AndrogenReceptor;EndogenousMetabolite作⽤通路:Others;MetabolicEnzyme/Protease储存⽅式:Powder-20°C3years4°C2yearsInsolvent-80°C6months-20°C1month溶解性数据体外实验Ethanol:50mg/mL(173.36mM;Needultrasonic)DMSO:50mg/mL(173.36mM;Needultrasonic)H2O:<0.1mg/mL(insoluble)SolventMass1mg5mg10mgConcentration制备储备液1mM3.4672mL17.3358mL34.6717mL5mM0.6934mL3.4672mL6.9343mL10mM0.3467mL1.7336mL3.4672mL请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。储备液的保存⽅式和期限:-80°C,6months;-20°C,1month。-80°C储存时,请在6个⽉内使⽤,-20°C储存时,请在1个⽉内使⽤。体内实验请根据您的实验动物和给药⽅式选择适当的溶解⽅案。以下溶解⽅案都请先按照InVitro⽅式配制澄的储备液,再依次添加助溶剂:为保证实验结果的可靠性,澄的储备液可以根据储存条件,适当保存;体内实验的⼯作液,建议您现⽤现配,当天使⽤;以下溶剂前显⽰的百分⽐指该溶剂在您配制终溶液中的体积占⽐;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的⽅式助溶1.请依序添加每种溶剂:10%DMSO40%PEG3005%Tween-8045%salineSolubility:≥2.5mg/mL(8.67mM);Clearsolution此⽅案可获得≥2.5mg/mL(8.67mM,饱和度未知)的澄溶液。以1mL⼯作液为例,取100μL25.0mg/mL的澄DMSO储备液加到400μLPEG300中,混合均匀;向上述体系中加⼊
50μLTween-80,混合均匀;然后继续加⼊450μL⽣理盐⽔定容⾄1mL。2.请依序添加每种溶剂:10%DMSO90%(20%SBE-β-CDinsaline)Solubility:≥2.5mg/mL(8.67mM);ClearsolutionPage1of2www.MedChemE此⽅案可获得≥2.5mg/mL(8.67mM,饱和度未知)的澄溶液。
以1mL⼯作液为例,取100μL25.0mg/mL的澄DMSO储备液加到900μL20%的SBE-β-CD⽣理盐⽔⽔溶液中,混合均匀。3.请依序添加每种溶剂:10%DMSO90%cornoilSolubility:≥2.5mg/mL(8.67mM);Clearsolution此⽅案可获得≥2.5mg/mL(8.67mM,饱和度未知)的澄溶液,此⽅案不适⽤于实验周期在半个⽉以上的实验。以1mL⼯作液为例,取100μL25.0mg/mL的澄DMSO储备液加到900μL⽟⽶油中,混合均匀。4.请依序添加每种溶剂:10%EtOH90%(20%SBE-β-CDinsaline)Solubility:≥2.5mg/mL(8.67mM);Clearsolution此⽅案可获得≥2.5mg/mL(8.67mM,饱和度未知)的澄溶液。以1mL⼯作液为例,取100μL25.0mg/mL的澄EtOH储备液加到900μL20%的SBE-β-CD⽣理盐⽔⽔溶液中,混合均匀。5.请依序添加每种溶剂:10%EtOH90%cornoilSolubility:≥2.5mg/mL(8.67mM);Clearsolution此⽅案可获得≥2.5mg/mL(8.67mM,饱和度未知)的澄溶液,此⽅案不适⽤于实验周期在半个⽉以上的实验。以1mL⼯作液为例,取100μL25.0mg/mL的澄EtOH储备液加到900μL⽟⽶油中,混合均匀。BIOLOGICALACTIVITY⽣物活性DHEA(Prasterone)最丰富的类醇激素之⼀。DHEA通过多种信号传导途径介导其作⽤,并通过转化成雄激素和雌
激素衍⽣物(例如,雄激素,雌激素,7α和7βDHEA(Prasterone),以及7α和7β表雄甾酮衍⽣物)通过其特异性受体
起作⽤。IC₅₀&TargetHumanEndogenousMetabolite体外研究DHEA(Prasterone)isaneffectiveantiapoptoticfactor,reversingtheserumdeprivation-inducedapoptosisinprostatecancercells(DU145andLNCaPcelllines)aswellasincoloncancercells(Caco2cellline).DHEA(Prasterone)significantlyreducesserumdeprivation-inducedapoptosisinall3cancercelltypes,quantitatedwiththeAPOPercentageassay(apoptosisisreducedfrom0.587±0.053to0.142±0.0016or0.059±0.002aftertreatmentfor12hourswithDHEAorNGF,respectively;n=3,P<0.01),andbyflowcytometryanalysis(FACS)forDU145cells.TheantiapoptoticeffectofDHEAisdosedependentwithanEC50atnanomolarconcentrations(EC50:11.2±3.6nMand12.4±2.2nMinDU145andCaco2cells,respectively)[1].DHEA(Prasterone)istheprincipalsexsteroidprecursorinhumansandcanbeconverteddirectlytoandrogens.DHEA(Prasterone)(≥1μM)causesadose-dependentinhibitionofChub-S7proliferation,asassessedbythymidineincorporationassays.DHEA(Prasterone)treatmentinhibitsexpressionofthekeyglucocorticoid-regulatinggenesH6PDH(≥100nM)andHSD11B1(≥1μM)indifferentiatingpreadipocytesinadose-dependentmanner.Inkeepingwiththisfinding,DHEA(Prasterone)treatment(≥1μM)resultsinamarkedreductionin11β-HSD1oxoreductaseactivity(≥1μM)andaconcurrentincreaseindehydrogenaseactivityatthehighestDHEAdoseused(25μMDHEA)indifferentiatedadipocytes[2].体内研究DHEA(Prasterone)inthediet(0.45%w/w)ofmaleB6mice(groupsoffivemice)treatedfor8weeksledtosignificantdecreasesinbodytemperaturecomparedwithmicefedthecontrolAIN-76Adiet.Asimilarcomparisonindicatedthatcontrolandpair-fedmicearealsosignificantlydifferent.AnimalsfedDHEA(Prasterone)havesignificantlylowertemperaturesthanmicefedthecontroldiet26/29timestested;micepairfedtothoseontheDHEA(Prasterone)dietarelessaffected,with8/29valuessignificantlylowerthaninmicefedAIN-76Aadlibitum.ThetemperaturesofmicefedDHEA(Prasterone)orpairfedtoDHEA(Prasterone)aresignificantlydifferent21/29timestested.BodyweightsaresignificantlygreaterinmicefedthecontroldietthaninmicefedDHEAorpairfedtoDHEA(Prasterone).Foodintake(gramsperday)fromcagesareaveragedforeachweek(n=7),exceptforWeek9(n=3).TheamountoffoodPage2of3www.MedChemEintakeissignificantlydecreasedinmicefedDHEA(Prasterone).Bydesign,micepairfedtoDHEA(Prasterone)ate
aboutthesameamount.Thus,itappearsthatDHEA(Prasterone)reducesbodytemperaturebyfoodrestrictionand
byaseparatemechanism[3].PROTOCOLCellAssay[2]Chub-S7preadipocytesandhumanprimarypreadipocytesareseededintoa24-wellplateatdensities1×105and2.5×105respectively.Followingovernightculture,mediumissupplementedwithDHEA,androstenediol,orDHEA(Prasterone)(0-100μM).Following24-,48-,or72hincubation,cellproliferationisassessedbyincubationwithradiolabeledthymidine(0.2μCi/well)forthefinal6hofculture.ProteinsareprecipitatedwithTCA,andcellsarescrapedinNaOH.Therespectivecontentofradiolabelednuclearmaterialintheresultinglysatesisanalyzedbyscintillationcounting[2].MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.AnimalMice[3]Administration[3]MicearefedPurinaLabChowuntilthestartofexperiments(Day0).GroupsoffivemicearethenfedpelletedAIN-76AdietcontainingeithernoadditiveorDHEA(0.45%w/w)between0900and1000hr.Dietsarestoredat4°Cfornolongerthansixmonthstomaintainoptimalactivity.Micearegiventhedietsadlibitum,exceptformicethatarepairfedtomicetreatedwithDHEA(Prasterone).TheamountsofAIN-76Adietthepair-fedmicereceivedaredeterminedbytheweightoffoodconsumedbytheDHEA-fedmiceonadailybasis.Bodyweights(grams)aremeasuredatdifferenttimepointsstartingatDay1andendingatDay59.Dailyfoodintakes(gramsperday)aredeterminedbyweighingthefoodconsumedpercageoffivemice.Themean±SEMvaluesarecalculatedforweeks1to8(n=7);week9hadonly3days.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.户使⽤本产品发表的科研⽂献•Aging(AlbanyNY).2020May14;12.•ToxicolApplPharmacol.2019Jun5:114612.Seemorecustomervalidationsonwww.MedChemEREFERENCES[1].AnagnostopoulouV,etal.Differentialeffectsofdehydro
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025年入党积极分子党校培训考试题库及答案(共740题)
- 2025年带式输送机操作工技能认定理论考试题(附答案)
- 关于余秋雨励志经典语录
- 2024年计算机二级考试知识要点归纳试题及答案
- 湖南省岳阳市湘阴县城南区2024-2025学年九年级下学期3月月考语文试题(原卷版+解析版)
- 家庭家教家风活动总结
- 工厂电工个人总结
- 2025超高层商务楼群不锈钢门窗施工合同
- 2025年度城市轨道交通建设合同(最终版)
- 企业借给个人借款合同范本
- 铁路涵洞及框架桥接长施工方案及方法
- 《管子》的智慧课件
- 物品交接确认书
- 水利工程质量管理讲义课件
- 张利《新营销》的完整版
- 四川省存量房买卖合同
- 2X型真空泵说明书
- 中考化学备考复习策略【最新实用精品】课件
- 药品说明书和标签管理规定(培训)课件
- YYT 0681.18-2020 无菌医疗器械包装试验方法 第18部分:用真空衰减法无损检验包装泄漏
- 三下健康成长教案
评论
0/150
提交评论